Jason E Dougherty

US Patent:

8428708, Apr 23, 2013

Filed:

May 21, 2012

Appl. No.:

13/476960

Inventors:

Bradley E. White - Mason OH, US
John Lemke - Pleasanton CA, US
Paul Hayter - Mountain View CA, US
Corinna X. Chen - Oakland CA, US
Brian W. Read - Brier WA, US
Jason E. Dougherty - Seattle WA, US

Assignee:

Incline Therapeutics, Inc. - Redwood City CA
Alza Corporation - Vacaville CA

International Classification:

A61N 1/30

US Classification:

604 20, 604501

Abstract:

Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e. g. , which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

US Patent:

8428709, Apr 23, 2013

Filed:

Jun 11, 2012

Appl. No.:

13/493314

Inventors:

Bradley E. White - Mason OH, US
Paul Hayter - Mountain View CA, US
John Lemke - Pleasanton CA, US
Scot Satre - Brentwood CA, US
Corinna X. Chen - Oakland CA, US
Brian W. Read - Brier WA, US
Jason E. Dougherty - Seattle WA, US

Assignee:

Incline Therapeutics, Inc. - Redwood City CA
Alza Corporation - Vacaville CA

International Classification:

A61N 1/30

US Classification:

604 20, 604 21, 604500, 604501, 607 62, 607 63, 607 64, 323265, 323283, 323284, 323285, 323286, 323287, 323288, 323289, 323290

Abstract:

Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e. g. , anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e. g. , cathode).

US Patent:

20060253232, Nov 9, 2006

Filed:

Mar 10, 2006

Appl. No.:

11/372565

Inventors:

Daniel Gerrity - Bellevue WA, US
Jason Dougherty - Renton WA, US
John Andersen - Tacoma WA, US
Stephen Fulton - Federal Way WA, US

Assignee:

NAVERUS, INC. - Renton WA

International Classification:

G08G 1/16

US Classification:

701016000, 701301000

Abstract:

A method () is disclosed for designing an RNP approach for an aircraft at a particular runway (). The method includes selecting a runway (), gathering obstacle data for the obstacle evaluation area (), selecting a VEB method and terms (), laying out a preliminary approach, inducing a missed approach segment (), calculating a preliminary obstacle clearance surface (), calculating a momentary descent segment using a physical model of the aircraft (), adjusting the obstacle clearance surface so that no obstacles intersect the surface (), and optionally optimizing the approach by departing from the operator's standard procedures (). Preferably, the obstacle clearance surface is adjusted so that it just touches an obstacle, without any object intersecting the surface, thereby providing an optimal decision altitude.

US Patent:

20130310729, Nov 21, 2013

Filed:

Apr 19, 2013

Appl. No.:

13/866371

Inventors:

Bradley E. WHITE - Mason OH, US
John LEMKE - Pleasanton CA, US
Paul HAYTER - Mountain View CA, US
Corinna X. CHEN - Oakland CA, US
Brian W. READ - Brier WA, US
Jason E. DOUGHERTY - Seattle WA, US

International Classification:

A61N 1/18

US Classification:

604 20

Abstract:

Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

US Patent:

20130332493, Dec 12, 2013

Filed:

May 30, 2013

Appl. No.:

13/905795

Inventors:

Jason Dougherty - Newcastle WA, US
Christopher Snideman - , US

Assignee:

Whispertrack - Truckee CA

International Classification:

G06F 17/30

US Classification:

707805

Abstract:

The embodiment of the invention is a method for airports, aircraft operators and other persons or entities to create, edit, and manage airport and navigation characteristics and have immediate, near real-time distribution (paper or electronic) of those characteristics to aircraft crews through the use of user interfaces and quality control.

US Patent:

20170239468, Aug 24, 2017

Filed:

May 8, 2017

Appl. No.:

15/589754

Inventors:

John LEMKE - Pleasanton CA, US
Scot SATRE - Brentwood CA, US
Corinna X. CHEN - Oakland CA, US
Brian W. READ - Brier WA, US
Zita S. NETZEL - Los Altos CA, US
David SEWARD - Seattle WA, US
Bradley E. WHITE - Lebanon OH, US
Paul HAYTER - Mountain View CA, US
Jason E. DOUGHERTY - Seattle WA, US

International Classification:

A61N 1/32
A61K 31/4468
B29C 65/48
B29C 65/56
A61N 1/08
A61M 37/00

Abstract:

A switch-operated therapeutic agent delivery device. Embodiments of the operated therapeutic agent delivery device my include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test. The switch operated therapeutic agent delivery device may have two parts, which are assembled by a user prior to use. These devices may be configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices may indirectly control and/or monitor the applied current without directly measuring from the cathode of the patient terminal.

US Patent:

20150338445, Nov 26, 2015

Filed:

Jul 31, 2015

Appl. No.:

14/815676

Inventors:

Bradley E. WHITE - Lebanon OH, US
John LEMKE - Pleasanton CA, US
Paul HAYTER - Mountain View CA, US
Corinna X. CHEN - Oakland CA, US
Brian W. READ - Brier WA, US
Jason E. DOUGHERTY - Seattle WA, US

International Classification:

G01R 19/145
G08B 21/18
G01R 19/165
A61N 1/30
A61N 1/08

Abstract:

Electrotransport drug delivery devices, system and methods of using configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices/systems may include an off-current module to determine that any current (e.g., which may be inferred by measuring potential difference between the anode and cathode of the device) flowing between the anode and cathode is below a threshold value when the device is not supposed to be delivering drug, thereby preventing unintended delivery of drug and/or alerting a user that unintended delivery of drug may occur.

US Patent:

20150196754, Jul 16, 2015

Filed:

Mar 5, 2013

Appl. No.:

14/406969

Inventors:

- Redwood City CA, US
- Vacaville CA, US
John Lemke - Pleasanton CA, US
Scot Satre - Brentwood CA, US
Corinna X. Chen - Oakland CA, US
Brian W. Read - Brier WA, US
Jason E. Dougherty - Seattle WA, US

Assignee:

ALZA CORPORATION - Vacaville CA
INCLINE THERAPEUTICS, INC. - Redwood City CA

International Classification:

A61N 1/32

Abstract:

Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).

Author:

Jason Dougherty

ISBN #:

0595277500